DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

10.75 -0.30 (-2.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $10.75 -2.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.83
Previous Close $11.05
Daily Range $10.67 - $11.34
52-Week Range $9.16 - $17.53
Market Cap $1.4B
P/E Ratio 157.86
Dividend (Yield) $0.00 (0.0%)
Volume 1,373,320
Average Daily Volume 1,300,570
Current FY EPS -$0.59

Sector

Healthcare

Industry

Drug Makers

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary Rss Feed

Why Shares of Nektar Therapeutics Are Buzzing Today

Is this meaningful? Or just another movement?

Nektar Announces Receipt of $40 Million Milestone Payment Resulting from First Commercial Sale of MO

Nektar Announces Receipt of $40 Million Milestone Payment Resulting from First Commercial Sale of MOVENTIG® (naloxegol) Tablets in Major European Market

Market Panic Has Created 'Compelling' Opportunities In Biotech

Relative Strength Alert For Nektar Therapeutics

Nektar Q2 Loss Wider-than-Expected, Outlook Maintained - Analyst Blog

Nektar Therapeutics' (NKTR) CEO Howard Robin on Q2 2015 Results - Earnings Call Transcript

Nektar Therapeutics (NKTR) Q2 2015 Results - Earnings Call Webcast

FBT, AMGN, TECH, NKTR: ETF Inflow Alert

Baxalta & Nektar Reveal Full Data from Hemophilia Study - Analyst Blog

Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks

Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention

Baxalta's BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A

See More NKTR News...

NKTR's Top Competitors

NKTR $10.75 (-2.71%)
Current stock: NKTR
TMO $121.45 (-3.13%)
Current stock: TMO
ILMN $193.13 (-2.27%)
Current stock: ILMN
WAT $118.36 (-2.49%)
Current stock: WAT